Methadone in combination with magnesium, ketamine, lidocaine, and dexmedetomidine improves postoperative outcomes after coronary artery bypass grafting: an observational multicentre study.

Autor: Weinberg L; Department of Anesthesia, Austin Health, Heidelberg, Australia. laurence.weinberg@austin.org.au., Johnston S; Department of Anesthesia, Austin Health, Heidelberg, Australia., Fletcher L; Department of Anesthesia, Austin Health, Heidelberg, Australia., Caragata R; Department of Anesthesia, Austin Health, Heidelberg, Australia., Hazard RH; Department of Anesthesia, Austin Health, Heidelberg, Australia., Le P; Department of Anesthesia, Austin Health, Heidelberg, Australia., Karp J; Department of Anesthesia, Austin Health, Heidelberg, Australia., Carp B; Department of Anesthesia, Austin Health, Heidelberg, Australia., Sean Yip SW; Department of Anesthesia, Austin Health, Heidelberg, Australia., Walpole D; Department of Cardiac Surgery, Epworth Eastern Hospital, Melbourne, Australia., Shearer N; Department of Anesthesia, Austin Health, Heidelberg, Australia., Neal-Williams T; Department of Anesthesia, Austin Health, Heidelberg, Australia., Nicolae R; Department of Anesthesia, Austin Health, Heidelberg, Australia., Armellini A; Department of Anesthesia, Austin Health, Heidelberg, Australia., Matalanis G; Department of Cardiac Surgery, Austin Hospital, Melbourne, Australia., Seevanayagam S; Department of Cardiac Surgery, Epworth Eastern Hospital, Melbourne, Australia., Bellomo R; Department of Intensive Care, Austin Health, Melbourne, Australia., Makar T; Department of Anesthesia, Austin Health, Heidelberg, Australia., Pillai P; Department of Anesthesia, Austin Health, Heidelberg, Australia., Warrillow S; Department of Intensive Care, Epworth Eastern Hospital, Melbourne, Australia., Ansari Z; Department of Intensive Care, Epworth Eastern Hospital, Melbourne, Australia., Koshy AN; Department of Cardiology, Austin Health, Melbourne, Australia., Lee DK; Department of Anesthesiology and Pain Medicine, Dongguk University Ilsan Hospital, Goyang, Republic of Korea., Yii M; Department of Cardiac Surgery, Epworth Eastern Hospital, Melbourne, Australia.
Jazyk: angličtina
Zdroj: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Jun 26; Vol. 19 (1), pp. 375. Date of Electronic Publication: 2024 Jun 26.
DOI: 10.1186/s13019-024-02935-0
Abstrakt: Background: An optimal pharmacological strategy for fast-track cardiac anesthesia (FTCA) is unclear. This study evaluated the effectiveness and safety of an FTCA program using methadone and non-opioid adjuvant infusions (magnesium, ketamine, lidocaine, and dexmedetomidine) in patients undergoing coronary artery bypass grafting.
Methods: This retrospective, multicenter observational study was conducted across private and public teaching sectors. We studied patients managed by a fast-track protocol or via usual care according to clinician preference. The primary outcome was the total mechanical ventilation time in hours adjusted for hospital, body mass index, category of surgical urgency, cardiopulmonary bypass time and EuroSCORE II. Secondary outcomes included successful extubation within four postoperative hours, postoperative pain scores, postoperative opioid requirements, and the development of postoperative complications.
Results: We included 87 patients in the fast-track group and 88 patients in the usual care group. Fast-track patients had a 35% reduction in total ventilation hours compared with usual care patients (p = 0.007). Thirty-five (40.2%) fast-track patients were extubated within four hours compared to 10 (11.4%) usual-care patients (odds ratio: 5.2 [95% CI: 2.39-11.08; p < 0.001]). Over 24 h, fast-track patients had less severe pain (p < 0.001) and required less intravenous morphine equivalent (22.00 mg [15.75:32.50] vs. 38.75 mg [20.50:81.75]; p < 0.001). There were no significant differences observed in postoperative complications or length of hospital stay between the groups.
Conclusion: Implementing an FTCA protocol using methadone, dexmedetomidine, magnesium, ketamine, lignocaine, and remifentanil together with protocolized weaning from a mechanical ventilation protocol is associated with significantly reduced time to tracheal extubation, improved postoperative analgesia, and reduced opioid use without any adverse safety events. A prospective randomized trial is warranted to further investigate the combined effects of these medications in reducing complications and length of stay in FTCA.
Trials Registration: The study protocol was registered in the Australian New Zealand Clinical Trials Registry ( https://www.anzctr.org.au/ACTRN12623000060640.aspx , retrospectively registered on 17/01/2023).
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje